Skip to main content
. 2018 Jun 14;33:269–275. doi: 10.1016/j.ebiom.2018.06.006

Table 2.

Baseline demographic and disease characteristics of randomized patients.

Characteristics CBMS group (n = 33) RBMS group (n = 33) P value
Age (yr)a 62·06 ± 6·98 61·58 ± 6·40 0·770
Sex 0·415
 Male 25 22
 Female 8 11
Tumor type 0·789
 Lung cancer 24 22
 Esophageal cancer 9 11
ECOG 0·523
 2 7 9
 3 20 21
 4 6 3
Location(s) of disease 0·422
 M or R or L 13 11
 M + R or M + L 11 8
 M + L + R 9 14
Length of stenosis 28·58 ± 6·77 27·61 ± 5·80 0·261
Stenosis grade 0·671
 2 3 4
 3 20 15
 4 6 8
 5 4 6
Dyspnea score 0·513
 2 19 17
 3 7 11
 4 7 5
Distant metastasis 0·375
 Yes 5 7
 No 28 26
Laboratory valuesa
White blood cell (×109/L) 8·12 ± 4·33 8·80 ± 3·95 0·356
 Immunoglobulin A 2·79 ± 1·16 2·67 ± 1·04 0·657
 Immunoglobulin G 11·81 ± 3·74 11·50 ± 3·26 0·847
 Immunoglobulin M 1·49 ± 0·70 1·52 ± 0·69 0·985

Abbreviation: CBMS = Conventional Bare Metal Stent; RBMS = Radioactive Bare Metal Stent; ECOG = Eastern Cooperative Oncology Group. M = Main; L = Left; R = Right

Note: Data are mean ± standard deviation.

Unless indicated, chi square test was used.

a

Independent samples t-test was used.